- Diagnosis of lung cancer2020 | Faculty of Medicine in Pilsen
- Immunotherapy in small cell lung cancer2021 | Faculty of Medicine in Pilsen
- Developmental trends and treatment of non-small cell lung cancer2012 | Second Faculty of Medicine
- Current review of immunotherapy and anti-angiogenic lung cancer treatment2019 | Faculty of Medicine in Pilsen
- Targeted therapy of non-small cell lung cancer2021 | Faculty of Medicine in Pilsen
- Current possibilities of radiotherapy of lung cancer and clinical recommendations2020 | Faculty of Medicine in Pilsen
- Radiotherapy in non-small-cell lung cancer 20162016 | Publication without faculty affiliation
- Endoscopic methods in diagnostic workup of lung cancer2020 | First Faculty of Medicine
- Personalized screeniong of lung carcinothed2013 | First Faculty of Medicine
- KRAS mutations in non-small cell lung cancer and options of treatment2020 | First Faculty of Medicine
- Imunoterapie u nemalobuněčného plicního karcinomu2016 | First Faculty of Medicine
- Topics of current lung cancer treatment imunoterapie, plicní karcinom, mutace, paliativní terapie in the Czech Republic to date 1. 8. 20202020 | Third Faculty of Medicine
- Cytokeratins and Lung Carcinomas.1999 | Faculty of Physical Education and Sport
- Prognostic and predictive markers in non-small cell lung cancer (NSCLC) - 1st part Summary Prognostic and predictive markers in non-small cell lung cancer (NSCLC) - 1st part Summary Prognostic and predictive markers in non-small cell lung cancer (NSCLC) - 1st part Summary PrognostiPrognostic and predictive markers in non-small cell lung cancer (NSCLC) - 1st part Summary Prognostic and predictive markers in non-small cell lung cancer (NSCLC) - 1st part2019 | Faculty of Medicine in Pilsen
- Osimertinib in treating advanced non-squamous non-small cell lung cancer2022 | First Faculty of Medicine
- First-line pembrolizumab for metastatic non-small-cell lung cancer2020 | First Faculty of Medicine
- Treatment options for non-small cell lung stage III cancer2021 | Faculty of Medicine in Pilsen, Third Faculty of Medicine
- Recurrent thromboembolism as the first manifestation of pulmonary carcinoma -case reports2018 | Publication without faculty affiliation
- Epidemiology of lung cancer in the czech republic and in the worldPublication without faculty affiliation
- Prognostic and predictive markers in non-small cell lung cancer (NSCLC) - 2nd part Summary2019 | Faculty of Medicine in Pilsen
- Adjuvant chemotherapy in the treatment of non-small cell lung cancer2007 | First Faculty of Medicine
- Videomediastinoscopy and videothoracoscopy in the staging of lung carcinoma +12004 | Faculty of Medicine in Pilsen, Central Library of Charles University
- The position of neoadjuvant chemotherapy within the treatment of non small cell lung cancer2007 | First Faculty of Medicine
- Expression of P53, P21 and bcl in Prognosis of Lung Carcinomas.1999 | Faculty of Physical Education and Sport
- Molecular pathology of pulmonary carcinomas2014 | Third Faculty of Medicine
- Targeted treatment of bronchogenic carcinoma2020 | First Faculty of Medicine
- Entrectinib v léčbě ROS1 pozitivního pokročilého nemalobuněčného plicního karcinomu a v léčbě solidních nádorů s NTRK fúzí2021 | First Faculty of Medicine
- Current recommendations for planning radiotherapy for non-small cell lung cancer Current recommendations for planning radiotherapy for non-small cell lung cancer Current recommendations for planning radiotherapy for non-small cell lung cancer Current recommendations for planning radiotherapy for non-small cell lung cancer2012 | Faculty of Medicine in Pilsen
- An overview of current options for the diagnosis and treatment of lung cancer2021 | Third Faculty of Medicine